DECIPHERA PHARMACEUTICALS (UK) LIMITED

Company number 12593299

Date	Type	Description	View / Download
19 Dec 2024	AP01	Appointment of Maria Ostrovsky as a director on 16 December 2024	(2 pages)
19 Dec 2024	TM01	Termination of appointment of Steven Larzelere Hoerter as a director on 16 December 2024	(1 page)
29 Nov 2024	AA01	Current accounting period extended from 31 December 2024 to 31 March 2025	(1 page)
26 Sep 2024	TM02	Termination of appointment of Jeffrey Michael Held as a secretary on 20 September 2024	(1 page)
12 Aug 2024	TM01	Termination of appointment of Thomas Patrick Kelly as a director on 8 August 2024	(1 page)
12 Aug 2024	AP01	Appointment of Jennifer Larson as a director on 8 August 2024	(2 pages)
14 May 2024	CS01	Confirmation statement made on 10 May 2024 with no updates	(3 pages)
29 Apr 2024	AA	Accounts for a small company made up to 31 December 2023	(7 pages)
14 Jul 2023	AA	Accounts for a small company made up to 31 December 2022	(6 pages)
11 May 2023	CS01	Confirmation statement made on 10 May 2023 with updates	(4 pages)
27 Sep 2022	AA	Accounts for a small company made up to 31 December 2021	(7 pages)
11 May 2022	CS01	Confirmation statement made on 10 May 2022 with updates	(4 pages)
28 Apr 2022	AD01	Registered office address changed from 11th Floor Whitefriars Lewins Mead Bristol BS1 2NT United Kingdom to Suite 2 First Floor 10 Temple Back Bristol BS1 6FL on 28 April 2022	(1 page)
17 Jul 2021	AA	Accounts for a small company made up to 31 December 2020	(7 pages)
22 Jun 2021	CS01	Confirmation statement made on 10 May 2021 with updates	(4 pages)
06 May 2021	CH01	Director's details changed for Mr Steven Larzelere Hoerter on 5 January 2021	(2 pages)
06 May 2021	CH01	Director's details changed for Mr Thomas Patrick Kelly on 5 January 2021	(2 pages)
28 Apr 2021	TM02	Termination of appointment of Vistra Cosec Limited as a secretary on 4 January 2021	(1 page)
05 Jan 2021	AA01	Previous accounting period shortened from 31 May 2021 to 31 December 2020	(1 page)
05 Jan 2021	AD01	Registered office address changed from Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB United Kingdom to 11th Floor Whitefriars Lewins Mead Bristol BS1 2NT on 5 January 2021	(1 page)
27 Nov 2020	PSC07	Cessation of Deciphera Pharmaceuticals Llc as a person with significant control on 23 November 2020	(1 page)
27 Nov 2020	PSC02	Notification of Deciphera Pharmaceuticals, Inc as a person with significant control on 23 November 2020	(2 pages)
27 Nov 2020	SH01	Statement of capital following an allotment of shares on 18 November 2020 GBP 2	(3 pages)
11 May 2020	NEWINC	Incorporation Statement of capital on 2020-05-11 GBP 1	(26 pages)